Cannabis Policy
FDA Outlines Plan to Improve CBD Research Data
The administration said it intends to use poison control records and other databases to better identify CBD products associated with adverse events. A new opt-in registry for CBD consumers is also in the works.
UK Regulator Grants Second Commercial License to Grow Medical Cannabis
The Jersey-based company has become the second cultivator in the British Isles to be licensed by the UK Home Office to grow pharmaceutical-grade cannabis for profit.
Oregon Regulators Recall Pesticide-contaminated Cannabis Products
The adult-use cannabis extracts and pre-rolls initially failed state testing requirements and are considered unsafe for consumers.
What Will 2021 Bring for The German Medical Cannabis Market?
It's already Europe’s largest legitimate medical industry. So, where does the Germany medical cannabis market go from here?
DEA Adds New Rule to Encourage Cannabis Research
The long-awaited rule should improve the quantity, quality, and accessibility of cannabis for scientific researchers in the US.
What Could California Learn from Michigan’s Cannabis Lab Standards?
Analytical Cannabis caught up with Josh Swider, CEO of Infinite Chemical Analysis Labs, to learn the differences between the cannabis testing regulators in California and Michigan, and what the former could learn from the latter.
Washington Cannabis Lab Suspended for Falsifying Test Results
The suspension, which came into effect on December 10, will remain active until June 8, 2021.
Sapphire Medical Foundation Awarded Charity Status in the UK
Britain’s first fund providing support for medical cannabis patients has been awarded official registered charity status, following a landmark decision from the UK’s Charity Commission.
The Top 10 Cannabis Stories of 2020
The year unlike any other has challenged just about every sector of society, but cannabis businesses, research centers and reform groups have still managed to make impressive headway.
